Semis At An Inflection Point… And Navigating An ‘Expensive’ Market 9/18/26
Summary
Fast Money examines semiconductor stocks at a crossroads, debating if AI capex will drive a breakout despite high valuations. The panel analyzes Apple’s iPhone 18 launch, Novo Nordisk’s investor day, and the rotation into healthcare. Additionally, they discuss the upcoming Trump-Xi summit, oil market impacts on rates, and strategies for navigating an expensive, concentrated market.
Topics discussed
Sponsorships: Vanguard and EY Parthenon
Show intro and segment previews
Semiconductor outlook and AI capex debate
SMH vs SOXX: Picking the better semi ETF
Hyperscaler monetization and market breadth
Memory pricing and passive investing trends
Healthcare and biotech sector performance
Interest rates, biotech correlation, and Lilly pipeline
GLP-1 competition: Lilly vs Novo Nordisk
GLP-1 pricing dynamics and consumer shift
Pharma strategy and Merck's Keytruda outlook
Sponsorships: Mazda and Vanguard
iPhone 18 Pro launch and demand analysis
Apple valuation, AI strategy, and margins
Sponsorships: Wise and ESPN
US-China tech summit and trade truce
US-Denmark security agreement on Greenland
China tech stocks and trade surplus impact
Market wrap: Dow, S&P, Nasdaq, and Crypto
Morgan Stanley view: Market concentration and diversification
AI enablers vs implementers and sector rotation
Fed outlook, oil prices, and bond opportunities
SpaceX S-1 risk factors and AI concerns
Nike struggles with Mbappe and competition
Disney hires Character.ai CEO as CTO
Legal disclaimer
Sponsorship: Venture Global
Listen ad-free on Castria